CNBC   |  April 22, 2014

Evolution of the activist investor

CNBC's David Faber speaks with Keith Meister, Corvex Management managing partner, about the role and engagement of the activist investor and shares his thoughts on Valeant Pharmaceuticals bid for Allergan.

Share This:

Sorry, we do not have a transcript available for this video at this time.